Summary by Futu AI
On May 3, 2024, Melody B. Meyer, reported a completed transaction involving the acquisition of 1,322 shares of AbbVie Inc. common stock at no cost. The transaction was classified as a grant. Following this transaction, Meyer's direct holdings in AbbVie Inc. increased to a total of 15,295 shares of common stock. The transaction reflects a continued investment in the company by Meyer, with the shares acquired directly indicating a vested interest in the company's performance.